E125068-10mgEntinostat (MS-275)
面议
- 阿拉丁
- 生产商
- E125068-10mg
- 现货
- 全国
规格 |
---|
耗材描述
- 分子式 C21H20N4O3
- 分子量376.41
- MDL号 MFCD03453552
属性
溶解性 | Soluble in methanol, DMSO (~30 mg/ml), DMF (~30 mg/ml), ethanol (~2 mg/ml), 1:1 solution of DMSO:PBS(PH7.2) (~0.5 mg/ml), and water (<1 mg/ml) at 25 °C. |
存贮条件 | 储存温度-20°C |
描述
应用 | An HDAC inhibitor shown to inhibit angiogenesis and metastasis. |
产品介绍 | Entinostat (MS-275)对HDAC1和HDAC3抑制作用强于与HDACs 4, 6, 8,和10,IC50分别为0.51 μM和1.7 μM。 |
备注 | Entinostat (MS-275) strongly inhibits HDAC1 and HDAC3 with IC50 of 0.51 μM and 1.7 μM, compared with HDACs 4, 6, 8, and 10. Phase 1/2. |
生化机理 | MS-275 is an inhibitor of HDAC (histone deacetylase) that preferentially inhibits HDAC1 (IC50 = 300 nM) over HDAC3 (IC50 = 8 μM). However, MS-275 does not inhibit HDAC8 (IC50 > 100 μM). MS-275 induces cyclin-dependent kinase inhibitor 1A (p21/CIP1/WAF1), slowing cell growth, differentiation, and tumor development in vivo. Recent studies suggest that MS-275 may be particularly useful as an antineoplastic agent when combined with other drugs, like adriamycin, inhibitors of poly (ADP-ribose) polymerase (PARP), or inhibitors of heat shock protein 90 (Hsp90). |
别名 | SNDX-275;恩替诺特; N-[[4-[[(2-氨基苯基)氨基]甲酰]苯基]甲基]氨基甲酸 3-吡啶基甲基酯;MS-275; SNDX-275; MS 275; SNDX 275;A HDAC1 and HDAC3 inhibitor;3-pyridinylmethyl [[4-[[(2-aminophenyl)amino]carbonyl]phenyl]methyl]carbamate; N-(2-Aminophenyl)-4-[N-(pyridine-3ylmethoxycarbonyl)aminomethyl]benzamide |
标识符号 | GHS06, GHS08 |
信号词 | Danger |
危害声明 | H301-H315-H319-H335-H360 |
警示性声明 | P201-P261-P301 + P310-P305 + P351 + P338-P308 + P313 |
WGK德国 | 3 |
猜你喜欢
感兴趣产品